Scott Cunning assists generic pharmaceutical companies by helping them bring generic versions of branded products to market. Scott also counsels tech companies helping them to navigate patent disputes in federal district courts. Scott’s clients value his tireless dedication and efforts to tailor his legal strategies to help their business succeed.
Scott’s experience has spanned a diverse variety of technological areas including semiconductor processing, digital data compression, implantable medical devices, medical imaging devices, electronic patient diaries and methods of drug delivery. He helps lawyers inside pharma and tech companies face high-risk patent litigation. Scott’s clients value that he invests time learning how his clients’ industries operate so that he can develop effective and efficient litigation strategies that will fit into their larger business objectives.
Scott has experience appearing before federal district courts throughout the country. Additionally, while attending The George Washington University Law School, Scott had the privilege to intern for the Honorable Richard Linn at the United States Court of Appeals for the Federal Circuit. Scott also served as the Executive Managing Editor for the AIPLA Quarterly Journal. In addition to his law degree, Scott holds a B.S. in chemical engineering.
Scott was selected for inclusion in Washington, D.C. Super Lawyers - Rising Stars Edition, Thomson Reuters, in Intellectual Property Litigation, 2014 and 2016.